Bio-Techne (TECH) Total Debt Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 6.94% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 50.25% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.07% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn | -18.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.92% |
| Dec 31, 2025 | 9.14% |
| Sep 30, 2025 | 3.31% |
| Jun 30, 2025 | 10.58% |
| Mar 31, 2025 | 8.41% |
| Dec 31, 2024 | 3.37% |
| Sep 30, 2024 | 0.82% |
| Jun 30, 2024 | -2.23% |
| Mar 31, 2024 | 23.20% |
| Dec 31, 2023 | 25.89% |
| Sep 30, 2023 | 11.70% |
| Jun 30, 2023 | -0.30% |
| Mar 31, 2023 | -3.18% |
| Dec 31, 2022 | -19.47% |
| Sep 30, 2022 | -17.59% |
| Jun 30, 2022 | -20.28% |
| Mar 31, 2022 | -20.85% |
| Dec 31, 2021 | -20.73% |
| Sep 30, 2021 | -19.52% |
| Jun 30, 2021 | 0.23% |
| Mar 31, 2021 | -19.32% |
| Dec 31, 2020 | -18.63% |
| Sep 30, 2020 | -5.74% |
| Jun 30, 2020 | -4.44% |
| Mar 31, 2020 | 0.21% |
| Dec 31, 2019 | -2.02% |
| Sep 30, 2019 | 7.30% |
| Jun 30, 2019 | 76.74% |
| Mar 31, 2019 | 49.02% |
| Dec 31, 2018 | 49.63% |
| Sep 30, 2018 | 50.60% |
| Jun 30, 2018 | 66.84% |
| Mar 31, 2018 | 267.00% |
| Dec 31, 2017 | 42.40% |
| Sep 30, 2017 | 50.05% |
| Jun 30, 2017 | 288.05% |